The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast

Background. Partial mastectomy is the method of choice for the surgical treatment of benign neoplasms (BN) of the breast. The drawback of this technique is the occurrence of residual cavities with the accumulation of serous and hemorrhagic exudate, promoting inflammation. Hydroxyethyl dimethyldihydr...

Full description

Bibliographic Details
Main Authors: Ramis M. Shabaev, Sergey A. Khodyrev, Irina V. Kolyadina, Dmitry A. Blagovestnov, Pavel M. Starokon
Format: Article
Language:Russian
Published: IP Habib O.N. 2023-12-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/627193/142917
_version_ 1797290154258333696
author Ramis M. Shabaev
Sergey A. Khodyrev
Irina V. Kolyadina
Dmitry A. Blagovestnov
Pavel M. Starokon
author_facet Ramis M. Shabaev
Sergey A. Khodyrev
Irina V. Kolyadina
Dmitry A. Blagovestnov
Pavel M. Starokon
author_sort Ramis M. Shabaev
collection DOAJ
description Background. Partial mastectomy is the method of choice for the surgical treatment of benign neoplasms (BN) of the breast. The drawback of this technique is the occurrence of residual cavities with the accumulation of serous and hemorrhagic exudate, promoting inflammation. Hydroxyethyl dimethyldihydropyrimidine (Ximedon) in the postoperative treatment improves the healing and overall treatment outcomes. Materials and methods. The study included 101 patients. All of them had a partial mastectomy for the BN. The study patients received different pharmacotherapy in the postoperative period. They were divided into two groups depending on the use of hydroxyethyl dimethyldihydropyrimidine. Group 1 included 52 (51.5%) patients who received hydroxyethyl dimethyldihydropyrimidine 2 hours before surgery and 0.5 g on days 1 to 7 in the postoperative period. Group 2 included 49 (48.5%) patients who had not received hydroxyethyl dimethyldihydropyrimidine. Results. Analysis of treatment outcomes showed that in group 1 patients receiving hydroxyethyl dimethyldihydropyrimidine, the overall treatment results were better. Therefore, hydroxyethyldimethyldihydropyrimidine improved overall treatment outcomes and increased patients' quality of life in the postoperative period. Conclusion. The use of hydroxyethyldimethyldihydropyrimidine in the postoperative period, which has a protective effect at the cellular level due to membrane-stabilizing, antioxidant, adaptogenic, and antibacterial properties, is promising and improves wound healing, thus improving the overall results of surgical treatment of breast BNs.
first_indexed 2024-03-07T19:16:21Z
format Article
id doaj.art-a173f94bbd3c4d3d840100bbdb8edf14
institution Directory Open Access Journal
issn 1815-1434
1815-1442
language Russian
last_indexed 2024-03-07T19:16:21Z
publishDate 2023-12-01
publisher IP Habib O.N.
record_format Article
series Современная онкология
spelling doaj.art-a173f94bbd3c4d3d840100bbdb8edf142024-02-29T13:31:29ZrusIP Habib O.N.Современная онкология1815-14341815-14422023-12-0125444044610.26442/18151434.2023.4.20251679543The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breastRamis M. Shabaev0https://orcid.org/0000-0002-0428-7454Sergey A. Khodyrev1https://orcid.org/0000-0002-9101-6029Irina V. Kolyadina2https://orcid.org/0000-0002-1124-6802Dmitry A. Blagovestnov3https://orcid.org/0000-0001-5724-6034Pavel M. Starokon4https://orcid.org/0000-0002-6512-9361Kirov Military Medical Academy – branch in MoscowKirov Military Medical Academy – branch in MoscowRussian Medical Academy of Continuous Professional EducationRussian Medical Academy of Continuous Professional EducationKirov Military Medical Academy – branch in MoscowBackground. Partial mastectomy is the method of choice for the surgical treatment of benign neoplasms (BN) of the breast. The drawback of this technique is the occurrence of residual cavities with the accumulation of serous and hemorrhagic exudate, promoting inflammation. Hydroxyethyl dimethyldihydropyrimidine (Ximedon) in the postoperative treatment improves the healing and overall treatment outcomes. Materials and methods. The study included 101 patients. All of them had a partial mastectomy for the BN. The study patients received different pharmacotherapy in the postoperative period. They were divided into two groups depending on the use of hydroxyethyl dimethyldihydropyrimidine. Group 1 included 52 (51.5%) patients who received hydroxyethyl dimethyldihydropyrimidine 2 hours before surgery and 0.5 g on days 1 to 7 in the postoperative period. Group 2 included 49 (48.5%) patients who had not received hydroxyethyl dimethyldihydropyrimidine. Results. Analysis of treatment outcomes showed that in group 1 patients receiving hydroxyethyl dimethyldihydropyrimidine, the overall treatment results were better. Therefore, hydroxyethyldimethyldihydropyrimidine improved overall treatment outcomes and increased patients' quality of life in the postoperative period. Conclusion. The use of hydroxyethyldimethyldihydropyrimidine in the postoperative period, which has a protective effect at the cellular level due to membrane-stabilizing, antioxidant, adaptogenic, and antibacterial properties, is promising and improves wound healing, thus improving the overall results of surgical treatment of breast BNs.https://modernonco.orscience.ru/1815-1434/article/viewFile/627193/142917benign neoplasm of the breastpartial mastectomyquality of lifehydroxyethyldimethyldihydropyrimidine
spellingShingle Ramis M. Shabaev
Sergey A. Khodyrev
Irina V. Kolyadina
Dmitry A. Blagovestnov
Pavel M. Starokon
The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
Современная онкология
benign neoplasm of the breast
partial mastectomy
quality of life
hydroxyethyldimethyldihydropyrimidine
title The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
title_full The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
title_fullStr The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
title_full_unstemmed The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
title_short The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
title_sort use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
topic benign neoplasm of the breast
partial mastectomy
quality of life
hydroxyethyldimethyldihydropyrimidine
url https://modernonco.orscience.ru/1815-1434/article/viewFile/627193/142917
work_keys_str_mv AT ramismshabaev theuseofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT sergeyakhodyrev theuseofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT irinavkolyadina theuseofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT dmitryablagovestnov theuseofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT pavelmstarokon theuseofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT ramismshabaev useofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT sergeyakhodyrev useofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT irinavkolyadina useofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT dmitryablagovestnov useofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast
AT pavelmstarokon useofhydroxyethyldimethyldihydropyrimidinetoimproveregenerationprocessesinapostoperativewoundaftersectoralresectionofthebreast